Advertisement
Screener

Codexis, Inc. (CDXS) Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount

2.8 / 5 stars · 68/120 Roast Me

Codexis, Inc. Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount

Codexis, Inc. (CDXS) reported Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount of $200.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-28.

Financial Statements › Notes › Debt and Equity Securities

us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount · last filed 2025-02-27

  • Codexis, Inc. equity securities without readily determinable fair value, upward price adjustment, annual amount for the quarter ending 2022-09-30 was $200.00K, a 71.43% decline year-over-year.
  • Codexis, Inc. equity securities without readily determinable fair value, upward price adjustment, annual amount for the quarter ending 2021-09-30 was $700.00K.
  • Codexis, Inc. equity securities without readily determinable fair value, upward price adjustment, annual amount for the quarter ending 2020-09-30 was $0.00.
  • Codexis, Inc. equity securities without readily determinable fair value, upward price adjustment, annual amount for fiscal 2023 was $200.00K, a 0.00% change from fiscal 2022.
  • Codexis, Inc. equity securities without readily determinable fair value, upward price adjustment, annual amount for fiscal 2022 was $200.00K, a 80.00% decline from fiscal 2021.
  • Codexis, Inc. equity securities without readily determinable fair value, upward price adjustment, annual amount for fiscal 2021 was $1.00M.
  • Codexis, Inc. equity securities without readily determinable fair value, upward price adjustment, annual amount for fiscal 2020 was $0.00.
Period endEquity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount 3 monthEquity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount 9 monthEquity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount 12 monthEquity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount 12 month as first filed
2023-12-31$200.00K
10-K · filed 2024-02-28
2022-12-31$200.00K
10-K · filed 2025-02-27
2022-09-30$200.00K
10-Q · filed 2022-11-04
2021-12-31$1.00M
10-K · filed 2023-02-27
$0.00
10-K · filed 2022-02-28
2021-09-30$700.00K
10-Q · filed 2022-11-04
$700.00K
10-Q · filed 2021-11-05
2020-12-31$0.00
10-K · filed 2022-02-28
2020-09-30$0.00
10-Q · filed 2021-11-05
$0.00
10-Q · filed 2021-11-05

Similar stocks

Stock NameCountryMarket CapPE Ratio
XCF Global, Inc. (SAFX)United States$0.171B-2.86
AEMETIS, INC (AMTX)United States$0.128B-1.95
Comstock Inc. (LODE)United States$0.195B-5.19
LanzaTech Global, Inc. (LNZA)United States$0.078B0.52
FutureFuel Corp. (FF)United States$0.225B-6.53
Alto Ingredients, Inc. (ALTO)United States$0.289B8.52
TOMI Environmental Solutions, Inc. (TOMZ)United States$0.012B
Gevo, Inc. (GEVO)United States$0.345B-1.72
Westlake Chemical Partners LP (WLKP)United States$0.754B2.35
Green Plains Inc. (GPRE)United States$1.054B8.70